New Study Finds This Common Supplement Cuts Dementia Risk by 40 Percent
Biochemist Rhonda Patrick shared a study published in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, which found a strong link between vitamin D supplementation and a lower risk of developing dementia.
Researchers followed over 12,000 people for a decade and discovered that those who took vitamin D supplements were 40 percent less likely to develop dementia compared to non-users. Within the first five years alone, 84 percent of supplement users remained dementia-free, while only 68 percent of non-users did.
The protective effects of vitamin D were especially strong in those with mild cognitive impairment or who carried the APOE4 gene, a well-known genetic risk factor for Alzheimer's.
Carriers of this gene can have an increased Alzheimer's risk, but vitamin D supplementation still appeared to reduce dementia risk by about 33 percent in this group.
Once processed by the body, vitamin D becomes a steroid hormone that influences over 1,000 genes, including many involved in brain health. It regulates nearly 5 percent of the human genome by entering cell nuclei and turning genes on or off, which plays a key role in everything from inflammation to neural communication.
Vitamin D deficiency is shockingly common, with about 70 percent of Americans falling into the deficient or insufficient range. Fortunately, supplementation can easily correct this.
Some small trials have also indicated that vitamin D supplementation may improve cognition in individuals with mild cognitive impairment or early Alzheimer's, though results in healthy adults are mixed.
If you're not getting enough sun, are over 50, or carry extra body fat, a daily vitamin D supplement could help bridge the gap. As always, consult with a healthcare provider to check your levels and determine the right dosage.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
27 minutes ago
FDA vaccine official restricted COVID vaccine approvals against the advice of agency staff
WASHINGTON -- The government's top vaccine official working under Health Secretary Robert F. Kennedy Jr. recently restricted the approval of two COVID-19 vaccines, disregarding recommendations from government scientists, according to federal documents released Wednesday. The new memos from the Food and Drug Administration show how the agency's vaccine chief, Dr. Vinay Prasad, personally intervened to place restrictions on COVID shots from vaccine makers Novavax and Moderna. Both vaccines were approved by the FDA in May after months of analysis by rank-and-file FDA reviewers. But internal correspondence show Prasad disagreed with staffers who planned to approve the shots for everyone 12 and older, similar to previous COVID vaccines. The scientists had concluded the benefit from the vaccines and the risk of COVID-19 outweighed the risk of possible side effects, which are rare. Instead Prasad decided the shots should be limited to those who face special risks from the virus— seniors or children and adults with underlying medical issues. Prasad explained that the COVID vaccine benefits must be reconsidered in light of falling rates of death and hospitalization and the possibility for vaccine side effects. It's the latest in a series of vaccine restrictions imposed by officials working under Kennedy, who has long questioned the benefits of vaccines. 'Even rare vaccination related harms both known and unknown now have higher chance of outweighing potential benefits' Prasad wrote in a five-page memo explaining his decision. COVID-19 remains a public health threat, resulting in 32,000 to 51,000 U.S. deaths and more than 250,000 hospitalizations since last fall, according to the Centers for Disease Control and Prevention. Most at risk for hospitalization are seniors and children under 2 — especially infants under 6 months. Top FDA leaders are typically not involved in the review of individual products. Officials like Prasad can overrule staffers, but such cases are rare and often controversial. News of the FDA documents was first reported by the New York Times. Prasad was hired to lead the FDA's vaccine center in May, after the previous director, Dr. Peter Marks, was forced to resign over disagreements with Kennedy. An academic researcher specializing in cancer therapies, Prasad came to prominence during the pandemic for criticizing public health measures, including the FDA's approval of COVID boosters for healthy adults and children. Since arriving at the agency he has worked with FDA Commissioner Mark Makary on new guidelines that will limit approvals of future COVID boosters to higher-risk Americans, mainly seniors and those with medical conditions like asthma and obesity. Those limits match the terms FDA recently approved for Novavax's shot, Nuvaxovid and Moderna's mNexspike. Novavax's vaccine is the only protein-based coronavirus vaccine available in the U.S. Moderna's vaccine is an updated, lower-dose version of its existing mRNA-based vaccine. The review team for the Novavax vaccine pointed to data from a study in 30,000 adults, concluding that 'the risk-benefit assessment for this vaccine technology remains favorable.' FDA staff reached a similar conclusion for the Moderna vaccine, deeming it similar in safety and effectiveness to the company's original shot. Last week, the FDA finalized new warning labeling about the risk of myocarditis, a rare form of heart inflammation, on shots from Moderna and Pfizer, the other maker of an mRNA-based shot for COVID. In his 'override memo,' reversing FDA staff's decision on the Moderna shot, Prasad pointed to the ongoing risk of myocarditis and questions about its frequency. The agency ordered Moderna to conduct further studies of the risk as a condition for the approving its updated shot. A spokesman for the administration said Prasad 'has raised serious concerns' about the issue. 'We will not ignore these risks and will ensure that the gold standard of science is used for any decisions,' said Andrew Nixon, in an emailed statement. Outside researchers have noted that cases of the heart condition tend to resolve quickly and are less severe than those associated with COVID infection itself, which can also cause myocarditis. ___
Miami Herald
2 hours ago
- Miami Herald
Trump's science cuts are great news — for other countries
Of all the questionable things President Trump has done recently — such as starting trade wars with traditional U.S. allies, threatening to invade friendly countries and pushing for bills that would balloon the U.S. deficit — one of the most important, yet least discussed, is his defunding of U.S. science programs. Since the start of his second term on Jan. 20, Trump has set in motion the most sweeping cuts to scientific research in modern U.S. history, including public grants for research into Alzheimer's, cancer and other major diseases. In addition to cutting research funds for leading U.S. universities, such as Harvard and Princeton, Trump's 2026 budget has led to the planned layoffs of thousands of scientists at some of the world's leading scientific institutions. Many U.S. scientists are now moving to Canada and Europe, where leaders in France and other countries have already opened their doors —and their budgets— to America's scientific refugees. A White House document proposing the 2026 budget calls for a 57% reduction for the U.S. National Science Foundation (NSF), which supports basic research in science and engineering, from $9 billion to $3.9 billion. It also calls for a 40% cut in the funding for the National Institutes of Health (NIH), the world's biggest public funder of biomedical research, from $47 billion to $27 billion. To put these figures in perspective, Trump's 'Big, beautiful bill,' which was close to being passed by Congress at the time of this writing, included $45 billion in new funds to build detention facilities — critics call them 'concentration camps' — for undocumented immigrants. As I have shown in previous columns, most current immigration detainees are not violent criminals, but hard-working people seeking a better life. Already, the NIH has canceled more than 2,400 research projects, the respected journal Nature reported on June 27. Trump's budget cuts to U.S. science are 'unprecedented,' and could have 'catastrophic effects,' Nature said in an earlier report on May. 15. The Trump administration says the NIH, NSF, NASA and other government-funded scientific institutions were rife with waste and politically-motivated 'woke' programs, and needed to be made more efficient. Many grants were awarded under non-scientific diversity, equity and inclusion (DEI) requirements that the Trump administration has now terminated, administration officials say. But most scientists say that, while there's probably some degree of waste in any large organization, Trump's budget cuts are a catastrophic overreaction. The administration is killing research programs that could save millions of lives in America and around the world, as well as crippling U.S. innovation in cutting-edge industries. Rep. Bill Foster, D-Illinois, the only member of Congress with a PhD in physics, told me in an interview that 'Trump is wrecking American science.' He added, 'I understand why you would have to cut things, including science. But this is done in a very sloppy and, frankly, stupid way.' Trump's budget cutters have simply looked for science programs that had the terms 'diversity,' or 'inclusion' somewhere in their paperwork, regardless of their merit, critics say. In many cases, such words were just included pro forma in top-quality scientific research programs. Foster told me he already knows of cases in which professors working on five-year research programs have just learned that their last year of funding is being cut off. They have had to lay off their research teams, leading many scientists to seek jobs abroad. 'Right now, America is bleeding scientific talent,' Foster told me. While much of the U.S. scientific leadership was built thanks to European scientists who moved to America in World War II, such as Nobel laureate Albert Einstein, the reverse trend is taking place now, he added. Indeed, French President Emmanuel Macron and European Commission President Ursula von der Leyen recently announced a $566 million plan at Sorbonne University to lure U.S. science refugees. The program is officially called 'Choose Europe for Science.' In an obvious reference to the United States, Macron said at the announcement ceremony that 'Nobody could imagine a few years ago that one of the great democracies of the world would eliminate research programs on the pretext that the word 'diversity' appeared in its program,' according to a New York Times report. When I asked Foster why he thinks Trump is crippling America's scientific programs, he said, 'I think he's trying to achieve popularity with his base, which comes largely from rural areas.' He added that people living in rural areas may not be fully aware of the benefits of science, and are more likely to blame intellectuals and scientists for the country's problems. Maybe so. But whatever the reason, crippling U.S. science will have dire consequences. America will pay not just in lost discoveries, but in lost lives, lost leadership and a diminished future for generations to come. Don't miss the 'Oppenheimer Presenta' TV show on Sundays at 9 pm E.T. on CNN en Español. Blog:
Time Business News
2 hours ago
- Time Business News
Healing with Care
Many people today look outside their own country to get health care. This is called medical tourism, and Thailand is one of the top places for it. In Thailand, you can find expert doctors, modern hospitals, and full medical packages at prices much lower than in the United States or Europe. Thailand gives you a chance to fix your health and enjoy a relaxing vacation at the same time. That is why more people are choosing to fly to Thailand for surgeries, checkups, and other treatments. Thailand is not just a place for beaches and food—it is also a smart place to take care of your health. Here is why: Hospitals in Thailand use new tools and machines, just like in the US or the UK Many doctors are trained in English-speaking countries You can book a full package, so everything is planned for you—hotel, transport, surgery, and recovery No long waiting lists—you get treated quickly Thailand also has kind nurses, clean hospital rooms, and a peaceful environment to help you heal. No matter what kind of help you need, there is a service for it in Thailand. At Bangkok Health Service, patients can choose from a wide range of medical options: Plastic Surgery – For those who want to change their look or fix past surgeries – For those who want to change their look or fix past surgeries Health Checkups – For early detection of problems like heart disease or diabetes – For early detection of problems like heart disease or diabetes Fertility Services – For couples wanting to have a baby – For couples wanting to have a baby Dental Treatments – For fixing teeth, whitening, and implants – For fixing teeth, whitening, and implants Cancer Screening – For peace of mind and early action – For peace of mind and early action Retirement Care – Safe and affordable living for elderly foreigners in Thailand These services are offered in top hospitals like Phyathai, Samitivej, and Bumrungrad. Medical costs in the US are very high. Many surgeries, even basic ones, can cost tens of thousands of dollars. In Thailand, the same surgery can cost 50–70% less. Here are some reasons Americans choose Thailand: Surgeries are cheaper but still very safe Patients receive full support, from airport pickup to hotel booking Easy communication—most staff speak English Thailand is a friendly, calm place for recovery Many treatments are not covered by insurance in the US, but are affordable in Thailand When people travel far from home, they want to feel safe. That's why Bangkok Health Service gives personal help to each patient. You are not alone. Support includes: Help picking the best hospital and doctor Booking your flight, hotel, and transport Translation and communication during your stay 24/7 contact if you need anything This means you can focus on getting better while someone else handles the details. Surgery always comes with some risks, no matter where you go. Bangkok Health Service now offers a special kind of insurance for surgery complications. This protects you in case something goes wrong after your treatment. Return flight if you need to come back for follow-up treatment Hospital costs for fixing the issue Medicine and aftercare related to the complication This insurance is helpful because: It removes the fear of 'what if something goes wrong' It gives you financial protection You can recover with confidence Learn more here: Surgery Complication Insurance Here are some of the top treatments people ask for when coming to Thailand: Vaser liposuction (especially six-pack shaping in Bangkok) (especially six-pack shaping in Bangkok) Plastic surgery holidays that mix travel and surgery that mix travel and surgery Retirement and care homes for aging expats for aging expats Medical holidays in Thailand that include both wellness and clinical care that include both wellness and clinical care Cosmetic surgery packages for face, eyes, tummy, and more Many of these treatments are part of easy-to-book medical tourism packages. The goal is to keep things simple and safe. Medical travel is great for many different people, such as: Adults who need surgery but cannot afford it in their home country Older people who want to retire in a warm and affordable place Young couples looking for IVF or fertility help Travelers who want to stay healthy while seeing the world Thailand gives each of them a fresh start, with better health and lower cost. It offers more than just treatment—it offers comfort, support, and peace of mind. With full packages, expert hospitals, and added services like surgery complication insurance, it is no wonder more people are booking their medical journeys here. TIME BUSINESS NEWS
